Literature DB >> 22447385

Fibrolamellar hepatocellular carcinoma with cardiac spread causing severe inferior vena cava obstruction in a 9-year-old child.

Jarrod D Knudson1, Jason F Goldberg, Nancy A Ayres.   

Abstract

Entities:  

Mesh:

Year:  2012        PMID: 22447385     DOI: 10.1007/s00246-012-0305-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


× No keyword cloud information.
  4 in total

Review 1.  Fibrolamellar hepatocellular carcinoma.

Authors:  Shu Liu; Kwok Wah Chan; Bingyuan Wang; Liang Qiao
Journal:  Am J Gastroenterol       Date:  2009-07-28       Impact factor: 10.864

2.  Characterization of cardiac tumors in children by cardiovascular magnetic resonance imaging: a multicenter experience.

Authors:  Rebecca S Beroukhim; Ashwin Prakash; Emanuela R Valsangiacomo Buechel; Joseph R Cava; Adam L Dorfman; Pierluigi Festa; Anthony M Hlavacek; Tiffanie R Johnson; Marc S Keller; Rajesh Krishnamurthy; Nilanjana Misra; Stephane Moniotte; W James Parks; Andrew J Powell; Brian D Soriano; Monvadi B Srichai; Shi-Joon Yoo; Jing Zhou; Tal Geva
Journal:  J Am Coll Cardiol       Date:  2011-08-30       Impact factor: 24.094

3.  Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies.

Authors:  K Y Lam; P Dickens; A C Chan
Journal:  Arch Pathol Lab Med       Date:  1993-10       Impact factor: 5.534

Review 4.  Review of the clinicopathologic features of fibrolamellar carcinoma.

Authors:  Michael Torbenson
Journal:  Adv Anat Pathol       Date:  2007-05       Impact factor: 3.875

  4 in total
  2 in total

1.  Duodenal Recurrence of Fibrolamellar Carcinoma 12 Years After Partial Hepatectomy and Adjuvant Chemotherapy.

Authors:  Héctor Adrián Díaz Hernández; Ismael Antonio Gómez Ruiz; Aldo Torre
Journal:  ACG Case Rep J       Date:  2016-11-23

Review 2.  Fibrolamellar carcinoma: 2012 update.

Authors:  Michael Torbenson
Journal:  Scientifica (Cairo)       Date:  2012-09-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.